Skip to main content

How to Treat Patients Who Refuse Needles

 

Case study:

A 47-year-old obese female patient who is hospitalized after undergoing major abdominal surgery, is afraid of needles and refuses to receive a prescribed shot of venous thromboembolism (VTE) prophylaxis. How should the situation be handled?

Answer:

Injectable blood-thinning drugs, such as heparin, can prevent venous thromboembolism (VTE), but upwards of 15% of prescribed doses are never administered to hospitalized patients, most often due to patient refusal, according to Brandyn D. Lau, MPH, an assistant professor of surgery at Johns Hopkins University School of Medicine. He said patients who refuse doses can be told that more people die from blood clots per year than from AIDs, breast cancer, and motor vehicles combined — which is true — but the goal should be to inform them about best practices in VTE prevention without scaring them into taking needed therapies. Dr. Lau was quick to point out that patients generally don’t want a lengthy bedside lecture about the pathophysiology of blood clots and pharmacologic treatment options. Instead, he said, they should be informed about the serious risks of blood clots and the importance of receiving preventative medications.

“Just having that conversation pulls patients into taking ownership in their own care,” said Dr. Lau. “Patients shouldn’t be forced to take medications, but they need to know that providers are trying to keep them as safe as possible.”

Pharmacy plays a huge role in those efforts, according to Dr. Lau, who said, “Clinical pharmacists actively monitor what medications patients take and know if prescribed therapies to prevent blood clots are actually administered.”

Pharmacists have a presence on hospital floors to watch the level of interaction between patients and providers and they’re knowledgeable about the latest options in chemical VTE prophylaxis. For example, pointed out Dr. Lau, novel oral anticoagulants are being explored as treatment options for lowering the risk of blood clots. “As a prevention strategy on the inpatient side, that could have a huge effect on the willingness of needle-phobic patients to receive the needed therapy,” said Dr. Lau.

But also keep in mind that not all documented patient refusals are what they seem. Dr. Lau explained that nurses often look at medication administration records, see that patients previously refused doses, and, instead of trying to convince them to accept prescribed VTE prophylaxis, will simply document that they refused doses again. “Those are missed opportunities to engage with patients, explain the harms of blood clots, and emphasize the benefits of the preventative medications,” said Dr. Lau.

His recent research showed an online education module involving scenario-based experiences, such as how to respond to patients who refuse prophylactic medications, was more effective than a PowerPoint slide show with traditional voice-over instruction in increasing the administration of prescribed doses of blood thinners at Johns Hopkins Hospital in Baltimore.

“Our study adds to evidence that the way something is taught to professionals has a great influence on whether they retain information and apply it,” said Dr. Lau. “Active learning seems to get better results than passive learning, showing that it’s not just what you teach, but also how you teach it.”

—Dan Cook